Search
for
Sort by
Research 61–90 of 78
- Finasteride-its impact on sexual function and prostate cancer
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement
- The connection of 5-alpha reductase inhibitors to the development of depression
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Male androgenetic alopecia
- Infranatant Portion of Microfragmented Adipose Tissue: A Promising Source of SVF for the Management of Androgenetic Alopecia
- Poster Abstracts
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Psychological interventions in the management of common skin conditions
- Sindrome post-finasteride: tra mito e realtà
- Post-finasteride syndrome - a true clinical entity?
- Possibilities and Limitations for Reversal of Age-Related Hair Loss
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Failing Public Health Again? Analytical Review of Depression and Suicidality From Finasteride
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Novel Technologies for Exploring the Skin–Brain Axis
- Hair Loss: Advances and Treatments
- Finasteride 5mg and Sexual Side Effects: How Many of these are Related to a Nocebo Phenomenon?
- The nocebo effect: A clinicians guide
- Nocebo effect in Dermatology
- Many sexual adverse effects of finasteride are attributable to a nocebo effect
- T07-O-05 Finasteride 5 mg and sexual side effects. How many of these are related to a nocebo phenomenon?
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- A comment on the post-finasteride syndrome
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Comment on Current Investigations into the Postfinasteride Syndrome
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Response to: “finasteride prescribed for hair loss consistently leads to depression”
- The difficult hair loss patient: A particular challenge